CTIG’S MPG APPROACH REDUCES EXECUTION RISKS TO DELIVER A BETTER RETURN FOR INVESTORS

CTIG’s clinical need-focused business model allows us to actively seek out and thoroughly vet new technologies to address therapeutic gaps that exist in Obesity, Cardiovascular surgery, Orthopedic, Metabolic Disorders, Wound Care, and Ophthalmology.

Strategic Alliance with Zühlke Ventures

CTIG has formed a strategic alliance with Zühlke Ventures to co-invest in all medical projects and leverage the extensive engineering expertise of the Zühlke Group. This also brings tremendous value to entrepreneurs and investors by ensuring that clinical validation is performed without seeking external capital.

Leveraging Existing Relationships with Major Medical Device Companies

CTIG Partners have built solid relationships with many medical device companies through previous successful acquisitions and continue to work with decision makers to deliver competitive products to their specific markets.